Business Wire

ELLIOTT-ADVISORS-UK-LTD

30.4.2018 08:02:09 CEST | Business Wire | Press release

Share
Elliott Advisors (UK) Limited Statement on Telecom Italia

Elliott Advisors (UK) Limited (“Elliott”) has had the opportunity in recent weeks to engage constructively with many of Telecom Italia’s (“TIM”, or the “Company”) key stakeholders, including the CEO Mr. Amos Genish, members of the management team, other shareholders and many other market participants.

Fundamentally, Elliott believes that Telecom Italia is uniquely positioned in the Italian market and operates an outstanding collection of assets with the potential to produce substantial, consistent returns for its shareholders while enhancing a nationally strategic infrastructure asset. However, poor stewardship under the Vivendi-controlled Board has resulted in deeply troubling corporate governance issues and a pervasive and persistent valuation discount. At this juncture, Elliott believes an independent Board of Directors is paramount to resolving these issues and to maximising value creation for all stakeholders.

With respect to certain value realisation opportunities put forward by Elliott on April 9th , Elliott believes that the management team led by Mr. Genish, together with an independent Board should evaluate whether and when to carry out strategic initiatives, in the best interest of value creation for all shareholders.

Regarding Netco, Elliott notes Mr. Genish’s statements on the possibility of selling a minority stake while retaining control:“…I have said to investors [that] we are ready to open a minority part of the capital and list the network provided that the future regulatory status is secure.” 1 Elliott trusts the management and an independent Board’s ability to evaluate these initiatives in the interest of maximizing shareholder value.

Further, with respect to the dividend, given the prospect of TIM achieving investment grade in 2018, Elliott accepts the importance of achieving this target before committing to pay a dividend.

In short, Elliott has sought to offer constructive ideas to enhance TIM’s value creation plan as presented by Mr. Genish on March 7th . There is no alternative business plan. Elliott and its proposed independent nominees fully support Mr. Genish and are encouraged that Mr. Genish has committed to remain at TIM to execute his plan with the full support of the Board of the Directors, regardless of its composition:

  • April 19th : “Elliott believes management should be led by the current CEO and the board of directors rather than by a single shareholder.” 2
  • April 24th : “We are very confident in the current management team led by the CEO Amos Genish.” 3
  • April 26th : We fully support TIM’s CEO, Mr. Amos Genish…We also support the business plan that Mr. Genish and his management team have put forward.” 4

Elliott seeks to ensure Mr. Genish and his entire management team are equipped to maximise the value creation attributable to TIM’s business plan by aligning TIM with international corporate governance best practices and equipping the Company with a qualified independent Board. To that end, Elliott has proposed a slate of ten independent, highly qualified, credible nominees that share Mr. Genish’s vision for TIM’s future and are fully supportive of TIM’s business plan.

To reiterate, if elected, the independent nominees would evaluate the merits of Elliott’s value creation proposals as described above in conjunction with management, to determine whether and when to implement them in the best interest of long-term value creation for all shareholders. Elliott is just a shareholder; TIM’s Board and management team will have the responsibility to address the optimal timing and strategy for the Company.

Elliott trusts shareholders will join it in setting the right conditions and appointing the right team at the Board level by voting for Elliott’s proposed slate on May 4th to allow TIM’s many stakeholders to thrive in the years ahead. With proper stewardship at the Board level, and a highly qualified independent Board of Directors, Elliott believes TIM’s prospects are bright.

Full materials and today’s presentation can be found at our dedicated website www.transformingtim.com .

About Elliott

Elliott Management Corporation manages two multi-strategy funds which combined have approximately $35 billion of assets under management. Its flagship fund, Elliott Associates, L.P., was founded in 1977, making it one of the oldest funds of its kind under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Management Corporation.

1 Interview with Mr. Genish in Les Echos, April 4th , https://www.lesechos.fr/tech-medias/hightech/0301514255731-amos-genish-vivendi-a-une-vision-long-terme-pour-telecom-italia-contrairement-a-elliott-2166165.php

2 Elliott statement, April 19th , https://www.transformingtim.com/media/1052/elliott-advisors-uk-limited-response-to-vivendi-statements.pdf

3 TIM AGM, April 24th , in conjunction with a vote in support of Mr. Genish as CEO

4 Elliott letter to shareholders, April 26th , https://www.transformingtim.com/media/1061/elliott_tim_letter_260418.pdf

Contact:

Media
London
Elliott Advisors (UK) Limited
Sarah Rajani CFA, +44 (0) 20 3009 1475
srajani@elliottadvisors.co.uk
or
Milan
Verini & Associates
Marcella Verini, +39 (02) 4539 5500
mverini@verinieassociati.com
or
Paris
Steele & Holt
Daphne Claude / Dominic Riding
+33 (0) 6 66 58 81 92 / +33 (0) 6 48 57 83 24
daphne@steeleandholt.com / dominic@steeleandholt.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release

- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built

DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release

DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict

Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release

Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye